用5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（DTIC）体内治疗的K36淋巴瘤免疫原性特性的变化 - Suppr

Suppr

超能文献

Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).

作者信息

Bonmassar A, Frati L, Fioretti M C, Romani L, Giampietri A, Goldin A

出版信息

Eur J Cancer (1965). 1979 Jul;15(7):933-9. doi: 10.1016/0014-2964(79)90276-7.

DOI:10.1016/0014-2964(79)90276-7

PMID:488153

Abstract

摘要

相似文献

Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).用5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（DTIC）体内治疗的K36淋巴瘤免疫原性特性的变化

Eur J Cancer (1965). 1979 Jul;15(7):933-9. doi: 10.1016/0014-2964(79)90276-7.

Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo.5-（3,3'-二甲基-1-三氮烯基）-咪唑-4-甲酰胺（DTIC）体内治疗的小鼠淋巴瘤中正常组织相容性抗原的表达

Eur J Cancer (1965). 1981 Apr;17(4):411-20. doi: 10.1016/0014-2964(81)90250-4.

Growth and rejection patterns of murine lymphoma cells antigenically altered following drug treatment in vivo.体内药物治疗后抗原性改变的小鼠淋巴瘤细胞的生长和排斥模式

Transplantation. 1978 Feb;25(2):63-8. doi: 10.1097/00007890-197802000-00005.

Drug-mediated immunogenic changes of virus-induced leukemia in vivo.药物介导的体内病毒诱导白血病的免疫原性变化。

Cancer Res. 1976 Apr;36(4):1347-52.

Cell kinetics and immunoegenicity of lymphoma cells treated with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DIC) in vivo.体内经5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（DIC）处理的淋巴瘤细胞的细胞动力学和免疫原性

Int J Cancer. 1977 May 15;19(5):664-9. doi: 10.1002/ijc.2910190510.

Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound.

J Natl Cancer Inst. 1980 Feb;64(2):297-301. doi: 10.1093/jnci/64.2.297.

Secondary cytotoxic response in vitro against Moloney lymphoma cells antigenically altered by drug treatment in vivo.针对体内经药物处理后抗原性发生改变的莫洛尼淋巴瘤细胞的体外继发性细胞毒性反应。

J Natl Cancer Inst. 1978 Jan;60(1):109-12. doi: 10.1093/jnci/60.1.109.

In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.体外产生针对体内经5-（3,3'-二甲基-1-三氮烯基）-咪唑-4-甲酰胺抗原性改变的L5178Y白血病的原发性细胞毒性淋巴细胞。

Transplantation. 1979 Sep;28(3):218-22. doi: 10.1097/00007890-197909000-00013.

Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo.

J Immunopharmacol. 1980;2(2):189-212. doi: 10.3109/08923978009026397.

Adoptive immunochemotherapy of a transplantable AKR leukemia (K36).

Int J Cancer. 1978 Feb 15;21(2):230-3. doi: 10.1002/ijc.2910210215.

引用本文的文献

Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?远隔效应与药物诱导的异种移植物形成：癌症治疗的战略联盟？

Int J Mol Sci. 2021 Oct 1;22(19):10672. doi: 10.3390/ijms221910672.

Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.肿瘤免疫疗法：药物诱导的新抗原（异种化）与免疫检查点抑制剂。

Oncotarget. 2017 Jun 20;8(25):41641-41669. doi: 10.18632/oncotarget.16335.

Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.转移中的肿瘤进展：一种使用凝集素抗性肿瘤变体的实验方法。

Cancer Metastasis Rev. 1982;1(2):99-140. doi: 10.1007/BF00048223.

Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.两种止吐方案不会损害5-（3,3-二甲基-1-三氮烯基）-咪唑-4-甲酰胺在体内诱导的化学异种移植。

Cancer Chemother Pharmacol. 1989;24(6):359-62. doi: 10.1007/BF00257442.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验